Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient

Affiliations

• ¹ Monash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
• ² Department of Microbiology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.
• ³ Monash Haematology, Monash Health, Clayton, Victoria, Australia.
• ⁴ Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
• ⁵ South Eastern Public Health Unit, Monash Health, Clayton, Victoria, Australia.
• ⁶ Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia.
• ⁷ Victorian Infectious Diseases Reference Laboratory, The University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
• ⁸ Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
• ⁹ Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
• ¹⁰ Department of Health and Human Services, Melbourne, Victoria, Australia.